Team:Queens Canada/Project/Attract

From 2013.igem.org

(Difference between revisions)
(Created page with "{{Template:Queens_Canada/qgemheader}}")
 
(34 intermediate revisions not shown)
Line 1: Line 1:
-
{{Template:Queens_Canada/qgemheader}}
+
{{Template:Queens_Canada/subheader}}
 +
 
 +
<html>
 +
<head>
 +
<link href='http://fonts.googleapis.com/css?family=Source+Sans+Pro' rel='stylesheet' type='text/css'>
 +
<style>
 +
<!-----ABOUT US----------->
 +
@font-face {
 +
        font-family: 'Source Sans Pro', sans-serif;
 +
}
 +
 
 +
.black{
 +
        font-family:'Source Sans Pro';
 +
        font-size:3em;
 +
        color:black;
 +
}
 +
 
 +
.rose{
 +
        font-family:'Source Sans Pro';
 +
        font-size:3em;
 +
        color:#bf3f3e;
 +
}
 +
 
 +
.content{
 +
        font-family:'Source Sans Pro';
 +
        font-size:1em;
 +
        color:black;
 +
}
 +
 
 +
/**-------- TAB --------- **/
 +
.project-buttons{
 +
        text-align:center;
 +
        font-size:1.7em;
 +
        font-family:bebasN;
 +
        height:40px;
 +
        vertical-align:middle;
 +
        padding-top:7px;
 +
        margin:0px;
 +
}
 +
.overview{
 +
        background-color:#f7e282;
 +
}
 +
a.over:link,a.over:visited{color:#ae9522;}
 +
.attract{
 +
        background-color:#fb9ebb;
 +
}
 +
a.att:link,a.att:visited{color:#f52666;}
 +
.repel{
 +
        background-color:#82e0f7;
 +
}
 +
a.rep:link,a.rep:visited{color:#0d5162;}
 +
</style>
 +
</head>
 +
 
 +
<body>
 +
<div class="header-bg">
 +
<div class="header-text">
 +
    QGEM 2013 PRESENTS:
 +
    </div>
 +
    <div class="header-logo">
 +
    <img src="https://static.igem.org/mediawiki/2013/c/c7/Projct.png" style="height:80px;" />
 +
  <a href="https://igem.org/Main_Page">
 +
                <img src="https://static.igem.org/mediawiki/2013/4/46/Igem_qgem_logo.png" class="img-circle" style="height:60px;min-width:60px;float:right;"></a>
 +
    </div>
 +
</div>
 +
 
 +
<div class="menuc" style="font-size:1.3em;">
 +
<ul>
 +
    <li id="home"><a href="https://2013.igem.org/Team:Queens_Canada">HOME</a></li>
 +
        <li id="team"><a href="https://2013.igem.org/Team:Queens_Canada/Team">TEAM</a></li>
 +
        <li id="project"><a href="https://2013.igem.org/Team:Queens_Canada/Project">PROJECT</a></li>
 +
        <li id="outreach"><a href="https://2013.igem.org/Team:Queens_Canada/Outreach">OUTREACH</a></li>
 +
        <li id="parts"><a href="https://2013.igem.org/Team:Queens_Canada/Parts">PARTS</a></li>
 +
        <li id="safety"><a href="https://2013.igem.org/Team:Queens_Canada/Safety">SAFETY</a></li>
 +
        <li id="sponsorship"><a href="https://2013.igem.org/Team:Queens_Canada/Sponsorship">SPONSORS</a></li>
 +
        <li id="judging"><a href="https://2013.igem.org/Team:Queens_Canada/Judging">JUDGING</a></li>
 +
        <li id="notebook"><a href="https://2013.igem.org/Team:Queens_Canada/Notebook">NOTEBOOK</a></li>
 +
    </ul>
 +
</div>
 +
 
 +
<div class="menuc disa" style="display:none;">
 +
<ul>
 +
    <li id="home"><a href="https://2013.igem.org/Team:Queens_Canada">HOME</a></li>
 +
        <li id="team"><a href="https://2013.igem.org/Team:Queens_Canada/Team">TEAM</a></li>
 +
        <li id="project"><a href="https://2013.igem.org/Team:Queens_Canada/Project">PROJECT</a></li>
 +
        <li id="outreach"><a href="https://2013.igem.org/Team:Queens_Canada/Outreach">OUTREACH</a></li>
 +
    </ul>
 +
</div>
 +
 
 +
<div class="menuc disa" style="display:none;">
 +
<ul>
 +
        <li id="parts"><a href="https://2013.igem.org/Team:Queens_Canada/Parts">PARTS</a></li>
 +
        <li id="safety"><a href="https://2013.igem.org/Team:Queens_Canada/Safety">SAFETY</a></li>
 +
        <li id="sponsorship"><a href="https://2013.igem.org/Team:Queens_Canada/Sponsorship">SPONSOR</a></li>
 +
        <li id="judging"><a href="https://2013.igem.org/Team:Queens_Canada/Judging">JUDGING</a></li>
 +
        <li id="notebook"><a href="https://2013.igem.org/Team:Queens_Canada/Notebook">NOTEBOOK</a></li>
 +
    </ul>
 +
</div>
 +
 
 +
<div class="row-fluid">
 +
        <div class="span4 project-buttons repel">
 +
                <a class="rep" href="https://2013.igem.org/Team:Queens_Canada/Project/Repel">REPEL</a>
 +
        </div>
 +
        <div class="span4 project-buttons overview">
 +
                <a class="test" href="https://2013.igem.org/Team:Queens_Canada/Project/Overview">OVERVIEW</a>
 +
        </div>
 +
        <div class="span4 project-buttons attract">
 +
                <a class="att" href="https://2013.igem.org/Team:Queens_Canada/Project/Attract">ATTRACT</a>
 +
        </div>
 +
</div>
 +
<div class="row-fluid">
 +
        <div class="offset1 span10" style="margin-top:40px;margin-bottom:40px;"><span class="rose">Trapping </span><span class="black">Mosquitoes</span></div>
 +
</div>
 +
 
 +
<div class="row-fluid" style="text-align:justify;">
 +
        <div class="offset1 span7 content">We intend to devise a mosquito trap where bacteria will synthesize the chemicals found in foot and body odour. Once the mosquitoes are trapped, we aim to further resolve disease by infecting the mosquitoes to sterilize, control, or destroy the vectors. Inspired by the recent finding of Dr. Fredros Okumu that a synthetic odour blend could be more attractive to a mosquito than a living human, we set out to devise a mosquito trap using synthetic biology. For example, a strain of yeast or bacteria could be engineered to produce CO<sub>2</sub>, body odour, and foot odour to lure the insects to their death with relative specificity. </div>
 +
        <div class="span4"><img src="https://static.igem.org/mediawiki/2013/4/4a/Mosquito_graph.jpg" style="height:250px;" /></div>
 +
        </div>
 +
 
 +
<div class="row-fluid">
 +
        <div class="offset1 span10" style="margin-top:40px;margin-bottom:40px;"><span style="line-height:50px"><span class="black">A Solution to </span><span class="rose">Insecticide and Drug Resistance</span></span></div></div>
 +
 
 +
<div class="row-fluid">
 +
        <div class="offset1 span10 content" style="text-align:justify;">A major roadblock in the eradication of malarial mosquitoes is their tendency to adapt their behavior and develop resistance to the solutions we devise. For example, insecticide-treated mosquito nets are becoming less and less effective because mosquitoes can develop diurnal feeding patterns to avoid them (<a href="http://jid.oxfordjournals.org/content/early/2012/09/20/infdis.jis565.abstract">http://jid.oxfordjournals.org/content/early/2012/09/20/infdis.jis565.abstract</a>). Similarly, the malaria parasite, <i>Plasmodium falciparum</i> can quickly become resistant to new drugs we develop to destroy it. Resistant strains have emerged even for the newest and most potent anti-malarial drug we have at our disposal, artemisinin (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495232/">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495232/</a>). Our solution circumvents this problem. The same thing that would grant mosquitoes resistance to the traps – i.e. becoming less sensitive to body odour – would also make it more difficult for them to find their human hosts. In this way, it may be possible to slow or even completely prevent mosquitoes from developing resistance to our intervention.</div></div>
 +
 
 +
<div class="row-fluid">
 +
        <div class="offset1 span10" style="margin-top:40px;margin-bottom:40px;"><span style="line-height:50px"><span class="rose">Indole Production</span><span class="black"> as a Proof of Concept</span></span></div></div>
 +
 
 +
<div class="row-fluid">
 +
        <div class="offset1 span10 content" style="text-align:justify;">We set out to synthesize indole as our first attractant. We chose the molecule for two reasons. First of all, it is produced endogenously in <i>E. coli</i> so the genes responsible for its synthesis and export, TnaA and TnaB, provided a natural target for PCR amplification. Once amplified, we could then clone the sequences into a plasmid with a strong constitutive promoter to produce the attractant in high yield. The second reason we chose indole is that there are known oderant binding proteins specific for it, and these receptors are highly conserved across mosquito species (<a href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020388/>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020388/</a>).
 +
 
 +
<br><br>
 +
        In our pathway, TnaB acts as a transporter, allowing for uptake of tryptophan into the bacteria. TnaA then acts as an enzyme to degrade tryptophan to indole. This ultimately allows for the production of indole in cells and if implemented in <i>E. coli</i> could be used to generate large amounts of the compound to act as an attractant.
 +
        </div>
 +
</div>
 +
<br>
 +
<center style="margin: 40 0;"><img src="https://static.igem.org/mediawiki/2013/3/3b/Tnaa_pathway.png" /></center>
 +
<br><br>
 +
<div class="row-fluid">
 +
        <div class="offset1 span6 content" style="text-align:justify;">
 +
        To that end we started off with using PCR to extract the endogenous genes from <i>E. coli</i>. We were successful in this endeavour, as the gel to the right shows 1.4kb bands which is the appropriate size for TnaA. However unfortunately, our attempts to ligate TnaA, TnaB, and a RBS did not prove successful despite numerous tries. This ended our work with this gene.
 +
        </div>
 +
        <div class="span4">
 +
                <img src="https://static.igem.org/mediawiki/2013/f/f4/TnaA_gel.jpg" style="height:250px;"/>
 +
        </div>
 +
</div>
 +
 
 +
<div class="row-fluid">
 +
        <div class="offset1 span10" style="margin-top:40px;margin-bottom:40px;"><span style="line-height:50px"><span class="black">Future Directions: </span><span class="rose">Infecting Mosquitoes</span></span></div></div>
 +
 
 +
<div class="row-fluid">
 +
        <div class="offset1 span10 content" style="text-align:justify;">If we were to use a species of bacteria in our trap that infected the mosquitoes and specifically affected their biology, such as by inhibiting the synthesis or action of transglutaminase in male mosquitoes, we could potentially do even more to prevent malaria. Inhibition of transglutaminase has been shown to prevent the formation of the male mating plug that is used to keep seminal fluid sealed in place. Because female mosquitoes only mate once in their life, mating with a male infected with the transglutaminase-blocking bacteria would sterilize the female as well, effectively doubling the number of mosquitoes the trap affects.</div></div>
 +
 
 +
<div class="row-fluid" style="margin-top:20px;margin-bottom:30px;">
 +
        <div class="offset1 span10 content" style="text-align:justify;">Infecting mosquitoes with bacteria is not a new concept, and there are a number of options in terms of the chassis that could be used. For example, Lausanne iGEM in 2010 characterized a new chassis, <i>Asaia</i> sp. that can live in the intestinal tract of mosquitoes and be transmitted both horizontally and vertically between mosquitoes. <i>Wolbachia</i> sp. is another strain of bacteria that has been shown to infect the mosquito that carries Dengue fever, <i>Aedes aegipti </i>with good stability (<a href="http://www.nature.com/nature/journal/v476/n7361/full/nature10356.html">http://www.nature.com/nature/journal/v476/n7361/full/nature10356.html</a>). If this strain could be shown to similarly affect <i>Anopheles gambiae</i>, it might also make an excellent choice of chassis for this purpose.</div></div>
 +
<br>
 +
<br>
 +
</body>
 +
</html>

Latest revision as of 23:43, 27 September 2013

Untitled Document

QGEM 2013 PRESENTS:
Trapping Mosquitoes
We intend to devise a mosquito trap where bacteria will synthesize the chemicals found in foot and body odour. Once the mosquitoes are trapped, we aim to further resolve disease by infecting the mosquitoes to sterilize, control, or destroy the vectors. Inspired by the recent finding of Dr. Fredros Okumu that a synthetic odour blend could be more attractive to a mosquito than a living human, we set out to devise a mosquito trap using synthetic biology. For example, a strain of yeast or bacteria could be engineered to produce CO2, body odour, and foot odour to lure the insects to their death with relative specificity.
A Solution to Insecticide and Drug Resistance
A major roadblock in the eradication of malarial mosquitoes is their tendency to adapt their behavior and develop resistance to the solutions we devise. For example, insecticide-treated mosquito nets are becoming less and less effective because mosquitoes can develop diurnal feeding patterns to avoid them (http://jid.oxfordjournals.org/content/early/2012/09/20/infdis.jis565.abstract). Similarly, the malaria parasite, Plasmodium falciparum can quickly become resistant to new drugs we develop to destroy it. Resistant strains have emerged even for the newest and most potent anti-malarial drug we have at our disposal, artemisinin (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495232/). Our solution circumvents this problem. The same thing that would grant mosquitoes resistance to the traps – i.e. becoming less sensitive to body odour – would also make it more difficult for them to find their human hosts. In this way, it may be possible to slow or even completely prevent mosquitoes from developing resistance to our intervention.
Indole Production as a Proof of Concept
We set out to synthesize indole as our first attractant. We chose the molecule for two reasons. First of all, it is produced endogenously in E. coli so the genes responsible for its synthesis and export, TnaA and TnaB, provided a natural target for PCR amplification. Once amplified, we could then clone the sequences into a plasmid with a strong constitutive promoter to produce the attractant in high yield. The second reason we chose indole is that there are known oderant binding proteins specific for it, and these receptors are highly conserved across mosquito species (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020388/).

In our pathway, TnaB acts as a transporter, allowing for uptake of tryptophan into the bacteria. TnaA then acts as an enzyme to degrade tryptophan to indole. This ultimately allows for the production of indole in cells and if implemented in E. coli could be used to generate large amounts of the compound to act as an attractant.



To that end we started off with using PCR to extract the endogenous genes from E. coli. We were successful in this endeavour, as the gel to the right shows 1.4kb bands which is the appropriate size for TnaA. However unfortunately, our attempts to ligate TnaA, TnaB, and a RBS did not prove successful despite numerous tries. This ended our work with this gene.
Future Directions: Infecting Mosquitoes
If we were to use a species of bacteria in our trap that infected the mosquitoes and specifically affected their biology, such as by inhibiting the synthesis or action of transglutaminase in male mosquitoes, we could potentially do even more to prevent malaria. Inhibition of transglutaminase has been shown to prevent the formation of the male mating plug that is used to keep seminal fluid sealed in place. Because female mosquitoes only mate once in their life, mating with a male infected with the transglutaminase-blocking bacteria would sterilize the female as well, effectively doubling the number of mosquitoes the trap affects.
Infecting mosquitoes with bacteria is not a new concept, and there are a number of options in terms of the chassis that could be used. For example, Lausanne iGEM in 2010 characterized a new chassis, Asaia sp. that can live in the intestinal tract of mosquitoes and be transmitted both horizontally and vertically between mosquitoes. Wolbachia sp. is another strain of bacteria that has been shown to infect the mosquito that carries Dengue fever, Aedes aegipti with good stability (http://www.nature.com/nature/journal/v476/n7361/full/nature10356.html). If this strain could be shown to similarly affect Anopheles gambiae, it might also make an excellent choice of chassis for this purpose.